Special Feature
Sequestration: What Does it Mean for US Pharma?
Lurking in the shadows of the US General Elections is something called the Sequestration Transparency Act. Of late, you may have read the occasional horror story about it. But what exactly is "sequestration", and what does it mean for US pharma? ...Read more
Advertisement
Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the “quality” of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using  case quality metrics while working with large and small pharmaceutical companies.
Contact Email:ask@sciformix.com |
Emerging Markets: BRIC
Takeda's Big Plans for BRIC — minus India
The completion last month of Takeda's $96 million production plant in Yaroslavl, Russia, is further proof of the company's rapid and expansive efforts to play 'catch-up' in the emerging markets, particularly the BRIC countries. That is, the BRIC countries minus India. Pharm Exec speaks to Takeda Chief Commercial Officer Dr. Frank Morich
...Read More
Advertisement
The Growing Role of the Patient in Cancer Treatment Selection
Live Webcast: Wednesday, October 17, 2012 at 11:00 AM EDT.
Register Free at  www.pharmexec.com/growing |
Emerging Markets: Specialty Drugs
Selling Speciality Drugs in China
Companies like Sanofi and Pfizer, despite their own in-country resources, are apparently achieving better returns after partnering with US-based SciClone Pharmaceuticals. SciClone CEO Friedhelm Blobel talks to Ben Comer ...Read More
Video
Pharm Exec's Industry Audit — Think Small, Be Stealthy
Pharm Exec Editor-in-Chief William Looney presents an overview of the magazine's lead feature this month
...Read more
Advertisement
Adopting a Pragmatic Approach to Compliance: Proactively Managing Aggregate Spend Data for Disclosure and Transparency Reporting .
Live Webcast: Tuesday, October 30, 2012 from 1:00 - 2:00 pm EDT
Register Free at  www.pharmexec.com/spenddata |
Forecast
Are We Over the Worst of the Patent Cliff?
In a bit of good news for pharma, Moody's Investors Service has upgraded its outlook for the global pharmaceutical industry to 'stable'
...Read more
Advertisement
Live On-Site, Online AUCTION of the SURPLUS PHARMACEUTICAL EQUIPMENT TO A MAJOR MANUFACTURER.
Auction begins Wednesday, October 17, 10 a.m. EDT at 100 Harrison St., Dover, NJ 07801. Inspection on-site on Tuesday, October 16 – 9 a.m. to 4 p.m. EDT
Features include Bohannon Capsule Filler • Patterson Kelly 10 CF Twin Shell Blender • Kilian Tablet Press, M#RUDH-20 • King TC8 Lane Counter • much more
Visit  www.schneiderind.com for all the details or, call 314-863-7711 |
|
|
|
 // Reckitt Benckiser (Parsippany, NJ) appointed Pfizer’s Tiffany McLaud to the position of Marketing Director, Healthcare. // Kantar Health (New York, NY) named Gary J. Gatyas Jr. as Senior Vice President, Global Marketing and Communications. // Tolera Therapeutics, Inc. (Kalamazoo, MI) announced appointment of Linda C. Hogan as Vice President of Business Development.// Lea Studer became Director of Marketing Communications at SCORR Marketing (Kearney, NE). |
|
